Real-world evidence and qualitative research: the ELICIT podcast
Merck on trends in oncology: the pharmaphorum podcast
Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast
Patient engagement strategies: the pharmaphorum podcast
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast
Virtual engagement and collaborations: the pharmaphorum podcast
Biotech Insight podcast: Overcoming planning challenges in oncology
Vertex senior country manager Nicola Massey: the pharmaphorum podcast
Regenerative medicine and COVID: the pharmaphorum podcast
Pharmacy and clinical research: the pharmaphorum podcast
Pharma’s post-COVID prospects: the pharmaphorum podcast
Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast
Big data and cell therapy development: the pharmaphorum podcast
GSK on COVID and vaccine development: the pharmaphorum podcast
The meaning of digital innovation: the pharmaphorum podcast
New ways to treat COVID: the pharmaphorum podcast
The Alderley Park Discovery Podcast: The journey to accessing science funding and investment
Roche on COVID healthcare and testing: the pharmaphorum podcast
Richard Francis discusses his new role as Purespring’s CEO: pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Ground Truths